Bhutan vs Mongolia: Proportion of isolates with decreased susceptibility or resistance
Bhutan
1
in 2020
Mongolia
0.7752
in 2018
Bhutan rank
8th
Mongolia rank
9th
Proportion of isolates with decreased susceptibility or resistance over time
- Bhutan
- Mongolia
How they compare
Bhutan currently reports 1 against 0.7752 in Mongolia, a difference of 0.2248.
That makes Bhutan's figure about 1.3 times Mongolia's.
Across all 5 years both countries report, Mongolia has been ahead every year.
Bhutan ranks 8th and Mongolia ranks 9th of 52 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 19.13 | 19.13 | Mongolia |
| 2010s | 0.872 | 14.1 | 13.23 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Bhutan or Mongolia?
- Bhutan, at 1 against 0.7752 in Mongolia as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Bhutan and Mongolia?
- 0.2248, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Mongolia?
- 5 years are reported by both, from 2009 to 2018.
- How do Bhutan and Mongolia rank globally for proportion of isolates with decreased susceptibility or resistance?
- Bhutan ranks 8th and Mongolia ranks 9th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.